|
Newsletter
"Join the senologic and
oncologic scientific
community" | | | | |
|
Gian Paolo Andreoletti, MD,
Editor-in-Chief - paolo.andreoletti@senology.it |
|
Educational
Grants - Sincere appreciation is
extended to the following companies for their generous support of
this activity:

Subscribe
Unsubscribe
Contact
Back
Issues
www.senology.org Home
Page |
|

Best Study of the Month
Vote for your favourite
study
Literature Selection
-
Gadalla SM et al.: "Breast cancer risk in elderly women with
systemic autoimmune rheumatic diseases: a population-based
case-control study",
Br J Cancer. 2009 Mar 10;100(5):817-21
-
Li Y et al.: "Wine, liquor, beer and risk of breast cancer in a
large population",
Eur J Cancer. 2009, March 6; 45(5): 789-794
-
Cummings SR et al.: "Prevention of Breast Cancer in
Postmenopausal Women: Approaches to Estimating and Reducing
Risk",
Natl Cancer Inst. 2009 Mar 10. [Epub ahead of print]
-
Carkaci S et al.: "Retrospective Study of 18F-FDG PET/CT in the
Diagnosis of Inflammatory Breast Cancer: Preliminary Data",
J Nucl Med. 2009; 50(2):231-238
-
Litton JK et al.: "Perception of screening and risk reduction
surgeries in patients tested for a BRCA deleterious mutation",
Cancer. 2009 Mar
11. [Epub ahead of print]
-
Beadle BM et al.: "The impact of pregnancy on breast cancer
outcomes in women </=35 years",
Cancer. 2009 Mar
15;115(6):1174-84
-
Coombs NJ et al.: "Internal mammary sentinel nodes: Ignore,
irradiate or operate?",
Eur J Cancer. 2009, March 6; 45(5): 789-794
-
Chagpar AB et al.: "Can sentinel node biopsy be avoided in some
elderly breast cancer patients?",
Ann Surg.
2009 Mar;249(3):455-60
-
Patani N et al.: "The clinical significance of sentinel lymph
node micrometastasis in breast cancer",
Breast Cancer Res Treat. 2009 Apr;114(3):393-402
-
Chadha M et al.: "Intraoperative high-dose-rate brachytherapy--a
novel technique in the surgical management of axillary
recurrence",
Breast J. 2009 Mar-Apr;15(2):140-5
-
Taylor CW et al.: "Estimating cardiac exposure from breast
cancer radiotherapy in clinical practice",
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1061-8
Comment
- "Impact of
locoregional treatment on the survival of breast cancer
patients with synchronous metastases"
- Romuald Le Scodan,
Department of Radiation Oncology, Centre René Huguenin,
Saint Cloud, France
"We
retrospectively studied the impact of locoregional treatment (LRT),
consisting mainly of locoregional radiotherapy (LRR) directed to
the breast and regional lymphatics, on the survival of breast
cancer patients with synchronous metastases. Among 581 eligible
patients treated in our institution between 1980 and 2004, 320
received LRT (group A) and 261 received no LRT (group B). With a
median follow-up of 39 months, the 3-year OS rates were 43.4%
and 26.7% in group A and group B (p=0.00002). The association
between LRT and improved survival was particularly marked in
women with visceral metastases. LRT was an independent
prognostic factor in multivariate analysis (....).
Our results confirm the survival advantage conferred by surgery
or radiation therapy of the primary tumor in breast cancer
patients with synchronous metastases. Well-designed prospective
studies, including locoregional radiotherapy as the only
locoregional treatment, are needed to re-evaluate treatment of
the primary breast tumor in patients with metastases at
diagnosis, and to identify those patients who are most likely to
benefit" (Comment
on:
Le Scodan R et al.: "Breast Cancer With Synchronous Metastases:
Survival Impact of Exclusive Locoregional Radiotherapy";
J Clin Oncol. 2009 Feb 9. [Epub ahead of print])
Press Releases
Images
Cystosarcoma phylloides

Stefano Ciatto, -
CSPO - Istituto Scientifico Prevenzione Oncologica,
Florence, Italy
Submit an
image
Calendar of Events
-
Kyoto Breast Cancer Conference, April 16-18, 2009,
Kyoto, Japan
-
2nd
International Breast Cancer Meeting,
April, 23-25, Sarajevo, Bosnia and
Herzegovina
-
Society of Breast Imaging
Biennal Meeting, April 25-29, Colorado Springs, CO,
USA - IMPAKT Breast
Cancer Conference, May 7-9, 2009, Brussels,
Belgium

Best Study of the Month
Vote for your favourite
study
Literature Selection
-
Key TJ et al.: "Cancer incidence in vegetarians: results from
the European Prospective Investigation into Cancer and Nutrition
(EPIC-Oxford)",
Am J Clin Nutr. 2009 Mar 11. [Epub ahead of print]
-
Shortt CP et al.: "Whole-Body MRI versus PET in assessment of
multiple myeloma disease activity",
AJR Am J Roentgenol. 2009 Apr;192(4):980-6
-
Andriole GL et al.: "Mortality Results from a Randomized
Prostate-Cancer Screening Trial",
N Engl J Med. 2009 Mar 18. [Epub ahead of print]
-
Schroder FH et al.: "Screening and Prostate-Cancer Mortality in
a Randomized European Study",
N Engl J Med. 2009 Mar 18. [Epub ahead of print]
-
Porter CR et al.: "Adjuvant radiotherapy after radical
prostatectomy shows no ability to improve rates of overall and
cancer-specific survival in a matched case-control study",
BJU Int. 2009 Mar;103(5):597-602
-
Menon U et al.: "Sensitivity and specificity of multimodal and
ultrasound screening for ovarian cancer, and stage distribution
of detected cancers: results of the prevalence screen of the UK
Collaborative Trial of Ovarian Cancer Screening (UKCTOCS",
Lancet
Oncol. 2009 Mar 10. [Epub ahead of print]
-
Evans MD et al.: "Outcomes of resection and non-resection
strategies in management of patients with advanced colorectal
cancer",
World J Surg Oncol. 2009 Mar 10;7(1):28. [Epub ahead of
print]
-
Genkinger JM et al.: "Alcohol Intake and Pancreatic Cancer Risk:
A Pooled Analysis of Fourteen Cohort Studies",
Cancer Epidemiol Biomarkers Prev. 20089 Mar 3 [Epub ahead
of print]
-
Sarpel U et al.: "Outcome for Patients Treated with Laparoscopic
Versus Open Resection of Hepatocellular Carcinoma: Case-Matched
Analysis",
Ann Surg Oncol. 2009 Mar 4. [Epub ahead of print]
-
Gore JL et al.: "Mortality increases when radical cystectomy is
delayed more than 12 weeks : results From a Surveillance,
Epidemiology, and End Results-Medicare Analysis",
Cancer. 2009 Mar
1;115(5):988-996
-
Gee JR et al.: "Reduced bladder cancer recurrence rate with
cardioprotective aspirin after intravesical bacille
Calmette-Guérin",
BJU Int.
2009 Mar;103(6):736-9
Comment
- "Corticosteroid treatment
in advanced metastatic cancer"
- Staffan
Lundstrom, Institute for Palliative
Medicine at San Diego Hospice, San Diego, CA, USA
"Symptom relieving therapy
with corticosteroids in advanced cancer is not just about
reducing physical symptoms such as nausea, appetite loss and
fatigue; there will probably also be consequences in other
dimensions of life. Even if the symptomatic improvement is
transient, the patient will probably experience strengthened
autonomy and maybe an increased hope, giving the impression of a
more normalized life. Knowing this, we can invite the patient
and his or her family to share thoughts about what is important
to accomplish, given a temporary improvement. This discussion
around goals of care is important not only for the patient, but
will help the palliative care team to plan in advance, providing
best possible support to the patient and family" (Comment
on:
Lindstrom S et al.: "The existential impact of starting
corticosteroid treatment as symptom control in advanced
metastatic cancer",
Palliat
Med. 2009; 23(2):165-70)
Press Releases
Clinical Guidelines
Healthcare Companies News
 Literature Selection
|
|
If this e-mail has reached you in
error, simply click on the following link and unsubscribe
yourself: Unsubscribe
Contact info - For
advertising information please contact: A&B@senology.it . For other enquiries, problems or
suggestions please contact: staff@senology.it
© A&B Edizioni
Medico-Scientifiche - Milan, Italy. Fax:
+39.035.7171000 | |